Principal Scientist, Downstream Process Development (Contract) - AW

Adverum BiotechnologiesRedwood City, CA
Onsite

About The Position

Adverum Biotechnologies, Inc., a subsidiary of Eli Lilly and Company, is seeking a Principal Scientist, Downstream Process Development to join their Process Development team in Redwood City, CA. This role focuses on developing and optimizing downstream processes for adeno-associated virus (AAV) gene therapy programs. Key responsibilities include late-stage process development, characterization, and tech transfer to support clinical and commercial manufacturing. The ideal candidate will have a strong understanding of chromatography, filtration, and gene therapy-specific challenges in AAV vector production, with experience in transitioning processes to GMP-compliant manufacturing.

Requirements

  • Ph.D. in Biochemistry, Chemical Engineering, Molecular Biology, or related field with 6+ years of relevant experience in downstream process development; or M.S. with 8+ years of experience.
  • Proven experience in AAV or other viral vector production, preferably in late-stage development for clinical/commercial scale manufacturing.
  • Strong expertise and in-depth knowledge in functioning and troubleshooting of purification process development/manufacturing equipment such as chromatography and filtration systems.
  • Experience with scalable, AKTA, depth filtration, and TFF systems.
  • Knowledge of GMP requirements and regulatory guidelines for gene therapy products.
  • Excellent problem-solving skills with the ability to troubleshoot and optimize complex bioprocesses.
  • Strong communication and leadership skills to manage cross-functional projects and mentor team members.

Nice To Haves

  • Knowledge of DOE principles, process characterization, and BLA enabling activities.
  • Background in authoring sections of regulatory submissions, including IND, or BLA filings.

Responsibilities

  • Support late‑stage AAV downstream process development and optimization to ensure scalability, robustness, reproducibility, and regulatory compliance.
  • Lead and execute purification development, including chromatography (AFF, IEX) and filtration (depth, NFF, TFF).
  • Author protocols and reports, and execute on process characterization and validation studies (FMEA, scale‑down models, DOE/OFAT, PPQ, hold studies).
  • Compile and analyze process and analytical data in Excel, JMP, or similar software, to identify trends, drive optimization, and lead and support investigations / RCA.
  • Present study findings, issues, and trends to PD and cross-functional CMC teams.
  • Support downstream material generation team as needed to maintain company timelines.
  • Act as a Downstream SME to support external manufacturing operations including technical meetings, BPR and related records review, execution, and troubleshooting.
  • Collaborate cross‑functionally (AD, USP, QC, RA) to ensure seamless transition from development to commercial.
  • Provide line leadership if needed.
  • Author/review technical documentation (development reports, SOPs, CMC sections for regulatory filings, Process Monitoring and Control Strategies).
  • Stay updated on industry trends and emerging technologies in gene therapy manufacturing to maintain best-in-class process development practices.

Benefits

  • Eli Lilly and Company benefits (implied by subsidiary status)
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service